Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Meningioma 1 (MN1) contains two sets of CAG repeats. Additionally we are shipping MN1 Proteins (3) and and many more products for this protein.
Showing 10 out of 35 products:
Human Polyclonal MN1 Primary Antibody for EIA, WB - ABIN953469
Kandilci, Grosveld: Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation. in Blood 2009
Show all 5 references for ABIN953469
Human Polyclonal MN1 Primary Antibody for ELISA, WB - ABIN1533846
Lekanne Deprez, Riegman, Groen, Warringa, van Biezen, Molijn, Bootsma, de Jong, Menon, Kley: Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. in Oncogene 1995
MN1 gene expression in acute myeloid leukemia (show BCL11A Antibodies).
MN1 deletion is associated with Craniofacial Abnormalities.
Chromosome 22q12.1 microdeletions involving the MN1 gene confirm it as a candidate gene for cleft palate.
MLL1 and DOT1L (show DOT1L Antibodies) cooperate with meningioma-1 to induce acute myeloid leukemia (show BCL11A Antibodies).
genotype-phenotype correlation among our patients and those previously reported with overlapping 22q12 deletions, we identified a 560 kb critical region containing the MN1 gene that is implicated in human cleft palate formation
these results suggest that deregulated MN1 expression contributes to the pathogenesis of pediatric B-ALL.
identified potential driver mutations in NF2 (neurofibromatosis type 2) and MN1 (meningioma 1).
cotransduction of an activated HOX (show MSH2 Antibodies) gene (NUP98HOXD13) with MN1 induces a serially transplantable acute myeloid leukemia (show BCL11A Antibodies) (AML (show RUNX1 Antibodies)).
MN1 overexpression independently predicts bad clinical outcome in CN-AML (show RUNX1 Antibodies) patients
High MN1 expression confers worse prognosis in Chinese adult patients with de novo acute myeloid leukemia (show BCL11A Antibodies).
Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4\\;22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis.
meningioma (translocation balanced)
, meningioma chromosome region 1
, probable tumor suppressor protein MN1